<DOC>
	<DOC>NCT00661297</DOC>
	<brief_summary>Study to investigate the efficacy and safety of Vardenafil</brief_summary>
	<brief_title>Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Heterosexual males &gt;/= 18 years old with ED for more than six months Subjects also needed a positive firsttime response to a single dose of 10mg vardenafil to be eligible for randomisation Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within prior 6 month Nitrate therapy Other exclusion criteria apply according to the Summary of Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Vardenafil</keyword>
</DOC>